Yttrium Y 90 Basiliximab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 90Y Basiliximab, Yttrium Y 90-DOTA-Basiliximab

Filter by location:

Duarte, California1 trial

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.